4//SEC Filing
Aisling Capital IV, LP 4
Accession 0000899243-19-010594
CIK 0001587221other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:15 PM ET
Size
11.5 KB
Accession
0000899243-19-010594
Insider Transaction Report
Form 4
Aisling Capital IV, LP
10% Owner
Transactions
- Award
Common Stock, par value of $0.0001
2019-04-11$3.50/sh+428,571$1,499,999→ 2,028,571 total
SCHIFF ANDREW N
10% Owner
Transactions
- Award
Common Stock, par value of $0.0001
2019-04-11$3.50/sh+428,571$1,499,999→ 2,028,571 total
Aisling Capital Partners IV, LP
10% Owner
Transactions
- Award
Common Stock, par value of $0.0001
2019-04-11$3.50/sh+428,571$1,499,999→ 2,028,571 total
Aisling Capital Partners IV LLC
10% Owner
Transactions
- Award
Common Stock, par value of $0.0001
2019-04-11$3.50/sh+428,571$1,499,999→ 2,028,571 total
ELMS STEVE
Director10% Owner
Transactions
- Award
Common Stock, par value of $0.0001
2019-04-11$3.50/sh+428,571$1,499,999→ 2,028,571 total
Footnotes (1)
- [F1]The securities are directly held by Aisling Capital IV, LP ("Aisling"), and may be deemed to be beneficially owned by Aisling Capital Partners IV, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners IV LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms.
Documents
Issuer
Zosano Pharma Corp
CIK 0001587221
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001652910
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:15 PM ET
- Size
- 11.5 KB